Amgen's launch of Amjevita, its nearly identical drug to Humira, cuts into what the "NYT" calls the "most lucrative franchise in pharmaceutical history." Read the whole story

Retailers are showing off new ideas for expanding their share of healthcare, including Kroger entering the clinical trials arena. Read the whole story

Johnson & Johnson (J&J) cannot use a bankruptcy filing to get around some 40,000 lawsuits seeking damages, a U.S. appeals court ruled. Read the whole story

Comirnaty (vaccine and boosters) revenues are expected to be $13.5 billion this year, down 64% from 2022, with Paxlovid (oral treatment) revenues down 58%. Read the whole story

From mahjong to chess to video games, ASICS is finding new ways to show people how exercise boosts cognitive function. Read the whole story

The new division is part of the company's mission to partner with brands focused on purpose-driven, life-saving work. Read the whole story

GoodRx has agreed to pay $1.5 million and to refrain from sharing users' health data for ad purposes, the FTC said Wednesday. News of … Read the whole story

Hamlin, the Buffalo Bills player who collapsed on field during a" Monday Night Football" telecast in early January, is helping the AHA promote hands-on … Read the whole story